• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Dyadic and Medytox to co-develop Covid-19 variant fighting vaccines pharmaceutical-business-review
    March 26, 2021
    US-based global biotechnology company Dyadic International has announced the expansion of its partnership with South Korea-based global research biopharmaceutical company Medytox to co-develop C1 manufactured Covid-19 vaccines.
  • Vaxine and Medytox partner on Covid-19 vaccine development pharmaceutical-technology
    May 27, 2020
    Australian biotechnology company Vaxine has collaborated with South Korean biopharma firm Medytox for the development and commercialisation of its Covid-19 vaccine candidate, COVAX-19.
  • Medytox files BLA of botulinum toxin biospectrumasia
    October 15, 2018
    If approved, the BTX product will be marketed locally by Medytox Taiwan, China, a joint venture between Medytox and Dynamic Medical Technologies, a Taiwan, Chinaese medical equipment company with a specialty in aesthetic lasers.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service